[1] |
Dinarello C A. Interleukin-1 beta. Crit Care Med,2005,33:S460-462.
|
[2] |
Apte R N, Voronov E. Interleukin-1—a major pleiotropic cytokine in tumor-host interactions. Semin Cancer Biol,2002,12:277 -290.
|
[3] |
Macri A, Versaci A, Loddo S,et al. Serum levels of interleukin-1 beta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer. Biomarkers,2006,11:184 -193.
|
[4] |
Yoshida N, Ikemoto S, Narita K, et al. Interleukin-6, tumour necrosis factor alpha and interleukin-1 beta in patients with renal cell carcinoma. Br J Cancer,2002,86:1396 -1400.
|
[5] |
Alexandrakis M G, Passam F H, Perisinakis K, et al. Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis. Respir Med,2002,96:553 -558.
|
[6] |
Jin L,Yuan R Q,Fuchs A,et al. Expression of interleukin-1 beta in human breast carcinoma. Cancer,1997,80:421 -434.
|
[7] |
Pantschenko A G,Pushkar I, Anderson K H,et al. The interleukin-1 family of cytokines and receptors in human breast cancer:implications for tumor progression. Int J Oncol,2003,23:269 -284.
|
[8] |
Dirix L Y, Dam P V, Prove A,et al. Inflammatory breast cancer: current understanding. Curr Opin Oncol,2006,18:563 -571.
|
[9] |
Elaraj D M,Weinreich D M,Varghese S,et al. The role of interleukin-1 in growth and metastasis of human cancer xenografts. Cli Cancer Res,2006,12:1088 -1096.
|
[10] |
Lee Y, Schwarz E, Davies M,et al. Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. J Orthop Res,2003,21:62 -72.
|
[11] |
Song X, Voronov E, Dvorkin E,et al. Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J Immunol,2003,171:6448 -6456.
|
[12] |
Apte R N, Krelin Y, Song X, et al. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis,tumour invasiveness and tumour- host interactions. Eur J Cancer,2006,42:751 -759.
|
[13] |
Seiji Y,Hiroshi N,Akihiko Y,et al. Multifunctional interleukin-1β promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasiveness- and angiogenesis-related molecules. Cancer Sci,2003,94:244 -252.
|
[14] |
Voronov E, Shouval D S, Krelin Y, et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA,2003,100:2645 -2650.
|
[15] |
Shchors K,SHchors E, Rostker F,et al. The Myc-dependent angiogenic switch in tumors is mediated by interleukin-1 beta. Genes Dev,2006,20:2527 -2538.
|
[16] |
Naomi K, Chikao M, Toshimichi Y,et al. Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology,2005,68:138 -145.
|
[17] |
Hwang Y S, Jeong M, Park J S,et al. Interleukin-1β stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells. Oncogene,2004,23:6603 -6611.
|
[18] |
Suswam E A, Nabors L B, Huang Y, et al. IL-1 beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3'untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR. Int J Cancer,2005,113:911 -919.
|
[19] |
Hwang Y S, Jeong M, Park J S,et al. Interleukin-1 beta stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells. Oncogene,2004,23:6603 -6611.
|
[20] |
Javier D, Manuel D, Díaz-Muoz, et al. Up-regulation of cyclooxygenase-2 by interleukin-1β in colon carcinoma cells. Cell Signal,2006,18:1262 -1269.
|
[21] |
Kuwano T, Nakao S, Yamamoto H,et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis.FASEB J,2004,18:300 -310.
|
[22] |
van Grevenstein W M, Holfland L J, Jeekel J,et al. The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial. Monolayers Pancreas,2006,32:396 -402.
|
[23] |
Song G, Ohashi T, Sakamoto N,et al. Adhesive force of human hepatoma HepG2 cells to endothelial cells and expression of E-selectin. Mol Cell Biomech,2006,3:61 -68.
|
[24] |
Deodutta R, Shubhashish S, Quentia F. Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells. Front Biosci,2006,11:889 -898.
|